Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer.

MLA

Xu, Yini, et al. “Inhibition of the RBMS1/PRNP Axis Improves Ferroptosis Resistance‐mediated Oxaliplatin Chemoresistance in Colorectal Cancer.” Molecular Carcinogenesis, vol. 63, no. 2, Feb. 2024, pp. 224–37. EBSCOhost, https://doi.org/10.1002/mc.23647.

APA

Xu, Y., Hao, J., Chen, Q., Qin, Y., Qin, H., Ren, S., Sun, C., Zhu, Y., Shao, B., Zhang, J., & Wang, H. (2024). Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer. Molecular Carcinogenesis, 63(2), 224–237. https://doi.org/10.1002/mc.23647

Chicago

Xu, Yini, Jingpeng Hao, Qiang Chen, Yafei Qin, Hong Qin, Shaohua Ren, Chenglu Sun, et al. 2024. “Inhibition of the RBMS1/PRNP Axis Improves Ferroptosis Resistance‐mediated Oxaliplatin Chemoresistance in Colorectal Cancer.” Molecular Carcinogenesis 63 (2): 224–37. doi:10.1002/mc.23647.